Anti-CD138 chimeric antigen receptor-modified T cell therapy for multiple myeloma with extensive extramedullary

Chen Tian1, Hongliang Yang2, Lei Zhu2

  • 1National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin Medical University Cancer Institute and Hospital, Tianjin, China. tcgirl2001@sina.com.

Abstract

No abstract available in PubMed .

Related Concept Videos